✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹30 Cr.
P/E
160.93
About
Omkar Pharmachem Ltd is engaged in the manufacturing of pharmaceutical chemicals.The product range of the company includes sodium bi-sulphite, sodium meta bi-sulphite, sodium sulphite, and sulphur.
Omkar Pharmachem Ltd is engaged in the manufacturing of pharmaceutical chemicals.The product r… Read more
Low
22
52W Range
High
30
  • Omkar Pharmachem
  • Concord Drugs
  • Guj. Inject (Kerala)

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

7 Yes

Positive for this company

3 Neutral

Neutral for this company

4 No

Negative for this company

3 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison
FAQs on Omkar Pharmachem Ltd. Business

Omkar Pharmachem Ltd specializes in manufacturing pharmaceutical chemicals such as sodium bi-sulphite, sodium meta bi-sulphite, sodium sulphite, and sulphur.

Omkar Pharmachem major competitors are Concord Drugs, Guj. Inject (Kerala), Medicamen Organics, Vineet Laboratories, Panjon, Kabra Drugs, Veerhealth Care.
Market Cap of Omkar Pharmachem is ₹30 Crs.
While the median market cap of its peers are ₹28 Crs.

Omkar Pharmachem seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material